Search
forLearn
5 / 801 resultsResearch
5 / 47 results
research REVIEW STUDY OF EFFECT OF MADHUKADI TAILA NASYA WITH PATOL PATRA SWARASA LEPA IN THE MANAGEMENT OF INDRALUPTA WITH SPECIAL REFRENCE TO ALOPECIA AREATA
The treatment may help regrow hair in Alopecia Areata.
research A REVIEW ON MALTADYA TAIL: A POLYHERBAL FORMULATION FOR INDRALUPTA
Maltadya Tail might be a good, affordable, and easy-to-use treatment for hair loss.
research Study on Samprapti of Khalitya W.S.R to Alopecia and to Evaluate the Upasaya with Bhringarajadi Taila.
Bhringarajadi Taila effectively reduces hair fall and promotes hair growth.
research A Case Study on OPD Level Management of Infertility due to PCOS with Ayurvedic Medicines
Ayurvedic treatment helped a woman with PCOS conceive and deliver a healthy baby.
research EFFECT OF KANCHNAR TWAK KWATH WITH SHUNTHI CHURNA AND NIMB TAIL NASYA IN HYPOTHYROIDISM: A CASE STUDY
Ayurvedic treatment improved symptoms and reduced TSH levels in a hypothyroidism patient.
Community Join
5 / 1000+ resultscommunity GT20029. Kintor Pharma’s Product
The conversation discusses GT20029, a compound by Kintor Pharma that degrades androgen receptors and is in trials, with potential as a hair loss cure. Another promising treatment mentioned is an antibody that blocks prolactin and has shown positive results in macaques.
community Simulative evaluation of taurine against alopecia caused by stress in Caenorhabditis elegans. - PubMed
Taurine shows potential in combating hair loss caused by chemical stress, especially when combined with other treatments like finasteride. Finasteride demonstrated better stress-reducing effects in the study.
community Potentially Positive Pyrilutamide News Coming
Kintor Pharmaceutical's stock rise suggests potential positive news about Pyrilutamide, a topical anti-androgen. GT20029 may also compete with existing treatments like finasteride and dutasteride.
community First patient dosed with Pyrilutamide (Kintor) Phase III
First patient dosed with Pyrilutamide (Kintor) Phase III for hair loss treatment. Pyrilutamide differs from approved treatments as it competes with DHT to bind hair follicles, potentially reducing side effects.
community Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US_Kintor Pharmaceutical Limited
Kintor Pharma finished enrolling and dosing participants in a Phase I trial for a hair loss treatment called AR-PROTAC (GT20029). The effectiveness of another drug, pyrilutamide (KX-826), for hair loss will be clearer after a Phase 2 trial expected to complete in January 2023.